Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis

[1]  Jane Worthington,et al.  A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations. , 2012, Human molecular genetics.

[2]  L. Bossini-Castillo,et al.  Unraveling the genetic component of systemic sclerosis , 2012, Human Genetics.

[3]  Raphael Zidovetzki,et al.  A Comprehensive Analysis of Shared Loci between Systemic Lupus Erythematosus (SLE) and Sixteen Autoimmune Diseases Reveals Limited Genetic Overlap , 2011, PLoS genetics.

[4]  P. Gregersen,et al.  Genomics and the multifactorial nature of human autoimmune disease. , 2011, The New England journal of medicine.

[5]  R. Toes,et al.  A common SNP in the CD40 region is associated with systemic lupus erythematosus and correlates with altered CD40 expression: implications for the pathogenesis , 2011, Annals of the rheumatic diseases.

[6]  Annette Lee,et al.  Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy , 2011, PLoS genetics.

[7]  Javier Martín,et al.  Influence of CD40 rs1883832 Polymorphism in Susceptibility to and Clinical Manifestations of Biopsy-proven Giant Cell Arteritis , 2010, The Journal of Rheumatology.

[8]  Luis Rodrigo,et al.  CD40: Novel Association with Crohn's Disease and Replication in Multiple Sclerosis Susceptibility , 2010, PloS one.

[9]  Annette Lee,et al.  Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus , 2010, Nature Genetics.

[10]  G. Bishop,et al.  CD40 and autoimmunity: the dark side of a great activator. , 2009, Seminars in immunology.

[11]  Pablo Moscato,et al.  Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 , 2009, Nature Genetics.

[12]  R. Noelle,et al.  Molecular mechanism and function of CD40/CD40L engagement in the immune system , 2009, Immunological reviews.

[13]  Jing Cui,et al.  Common variants at CD40 and other loci confer risk of rheumatoid arthritis , 2008, Nature Genetics.

[14]  C. Erausquin,et al.  Association of the microsatellite in the 3' untranslated region of the CD154 gene with rheumatoid arthritis in females from a Spanish cohort: a case-control study , 2007, Arthritis research & therapy.

[15]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[16]  M. Fujimoto,et al.  Increased serum soluble CD40 levels in patients with systemic sclerosis. , 2007, The Journal of rheumatology.

[17]  A. Siegbahn,et al.  Soluble CD40L Levels Are Regulated by the −3459 A>G Polymorphism and Predict Myocardial Infarction and the Efficacy of Antithrombotic Treatment in Non-ST Elevation Acute Coronary Syndrome , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[18]  C. Langefeld,et al.  Variants of the CD40 gene but not of the CD40L gene are associated with coronary artery calcification in the Diabetes Heart Study (DHS). , 2006, American heart journal.

[19]  G. Abecasis,et al.  Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies , 2006, Nature Genetics.

[20]  Taiji Oashi,et al.  A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. , 2005, Endocrinology.

[21]  M. Daly,et al.  Haplotype structure of TNFRSF5-TNFSF5 (CD40–CD40L) and association analysis in systemic lupus erythematosus , 2005, European Journal of Human Genetics.

[22]  V. Lougaris,et al.  Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features , 2005, Immunological reviews.

[23]  D. Borderie,et al.  Increased plasma soluble CD40 ligand concentrations in systemic sclerosis and association with pulmonary arterial hypertension and digital ulcers , 2004, Annals of the rheumatic diseases.

[24]  C. Rodríguez-Gallego,et al.  The dinucleotide repeat polymorphism in the 3′UTR of the CD154 gene has a functional role on protein expression and is associated with systemic lupus erythematosus , 2004, Annals of the rheumatic diseases.

[25]  N. Kamatani,et al.  Increased CD40 expression in skin fibroblasts from patients with systemic sclerosis (SSc): role of CD40‐CD154 in the phenotype of SSc fibroblasts , 2003, European journal of immunology.

[26]  T. Kipps,et al.  Soluble CD154 in rheumatoid arthritis: elevated plasma levels in cases with vasculitis. , 2001, The Journal of rheumatology.

[27]  T. Medsger,et al.  Criteria for the classification of early systemic sclerosis. , 2001, The Journal of rheumatology.

[28]  R. Vakkalanka,et al.  Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera. , 1999, Arthritis and rheumatism.

[29]  M. Béné,et al.  Coexpression of CD40 and class II antigen HLA-DR in Graves' disease thyroid epithelial cells. , 1997, Clinical immunology and immunopathology.

[30]  T. Medsger,et al.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.

[31]  M. Kozak.  An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. , 1987, Nucleic acids research.

[32]  A. Masi.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.

[33]  James F. Fries,et al.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.